Humana (NYSE:HUM) Hits New 52-Week Low – What’s Next?

Humana Inc. (NYSE:HUM) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $181.32 and last traded at $182.1070, with a volume of 2495839 shares changing hands. The stock had previously closed at $189.49.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. KeyCorp restated a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Wolfe Research increased their price objective on shares of Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a report on Thursday, January 8th. The Goldman Sachs Group reduced their target price on Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a report on Monday, November 24th. Barclays reaffirmed an “underperformer” rating on shares of Humana in a research note on Monday, January 5th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $344.00 target price on shares of Humana in a research report on Tuesday, January 6th. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $293.21.

Humana Trading Down 4.4%

The stock has a market cap of $21.78 billion, a PE ratio of 16.97, a PEG ratio of 1.61 and a beta of 0.44. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The stock has a fifty day moving average price of $250.49 and a 200 day moving average price of $262.76.

Hedge Funds Weigh In On Humana

A number of large investors have recently made changes to their positions in the company. Sound View Wealth Advisors Group LLC lifted its stake in shares of Humana by 3.5% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock worth $272,000 after acquiring an additional 36 shares during the last quarter. Unison Advisors LLC boosted its stake in shares of Humana by 0.4% during the third quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock valued at $2,646,000 after purchasing an additional 37 shares during the period. CoreCap Advisors LLC grew its holdings in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the last quarter. Insigneo Advisory Services LLC lifted its holdings in Humana by 3.0% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock valued at $386,000 after buying an additional 43 shares in the last quarter. Finally, Columbus Macro LLC boosted its position in Humana by 5.5% in the 4th quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock valued at $210,000 after buying an additional 43 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.